Clin2
NCT05117723Possibly a fitRecruiting

IPMN cyst database to help predict pancreatic cancer risk

IPMN, PancreaticIPMN

Part of Cancer, Digestive system, Hormones & metabolism clinical trials.

This study collects information from people who have an IPMN cyst in the pancreas to help predict who may be at higher risk of pancreatic cancer. It may help your care team estimate risk and plan follow-up more effectively.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,000 people
Ages
18 years to 90 years
Study type
Observational

Who can take part

  • Be an adult age 18 to 90 years old
  • Have pancreatic cysts on imaging that look like IPMN
  • Have been identified as having an IPMN-consistent cystic mass
  • Not formally decline enrolling in the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06694792Recruiting
Study on markers to find invasive IPMN

This trial looks for markers in cyst fluid and tissue to help identify which IPMN growths are becoming invasive (spreading). It may help doctors decide who needs surgery.

Milan, MI
NCT06574373Recruiting
Finding new markers for pancreatic IPMN progression

This study looks for new markers in the blood or tissues of people with a pancreatic condition called IPMN. The goal is to find better ways to predict if IPMN might turn into cancer and to help choose the best treatment.

Roma
NCT07014709Not yet recruiting
GLP-1 drugs and IPMN (pancreatic cysts)

This study looks at how GLP-1 receptor agonists (medications used for diabetes and weight loss) might affect people with IPMN (a type of pancreatic cyst). The goal is to see if these drugs change the size or growth of the cysts.

Villars-sur-Glâne
NCT07056972Not yet recruiting
Stopping scans for stable pancreatic cysts

This study looks at whether people aged 70 and older with a certain type of stable pancreatic cyst (called BD-IPMN) can safely stop having follow-up scans. If you have had these cysts for at least 5 years without any worrying changes, this trial may help you avoid unnecessary testing.

NCT06706700Recruiting
Biomarkers to predict cancer risk in pancreatic IPMN

This trial studies whether blood markers can help predict which pancreatic IPMNs are likely to become cancerous. If successful, it could help doctors decide when surgery is needed.

Milan, Italy
NCT06000553Not yet recruiting
Early detection of pancreatic cancer in people with certain pancreatic cysts

This trial tests whether regular MRI scans can help catch pancreatic cancer early in people who have intermediate- or high-risk IPMN (a type of pancreatic cyst). It aims to find cancer sooner to improve treatment options.

Hear when a new IPMN, Pancreatic trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.